Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Read more
Pfizer Pledges $100 Million to New Industry Fund to Help Fight Growing Threat of Antimicrobial Resistance Read more
Numab and Boehringer Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases Read more
Moderna Completes Enrollment of Phase 2 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273) Read more
Xencor and Atreca Enter Strategic Collaboration to Discover, Develop and Commercialize Novel T Cell Engaging Bispecific Antibodies Read more
Concert Receives FDA Breakthrough Therapy Designation for CTP-543 for the Treatment of Alopecia Areata Read more
LYNPARZA (olaparib) Approved in the EU for Germline BRCA-mutated Metastatic Pancreatic Cancer Read more
Corvus Pharmaceuticals Initiates Clinical Trial of Novel Immunotherapy for Patients with COVID-19 Read more